NO20001459D0 - Anvendelse av kombinasjoner som innbefatter ikke-sedative antihistaminer og <alfa>-adrenerge legemidler for topisk behandling av rhinitt/konjunktivitt og forkjølelse, forskjølelseslignende og/eller influensasymptomer - Google Patents
Anvendelse av kombinasjoner som innbefatter ikke-sedative antihistaminer og <alfa>-adrenerge legemidler for topisk behandling av rhinitt/konjunktivitt og forkjølelse, forskjølelseslignende og/eller influensasymptomerInfo
- Publication number
- NO20001459D0 NO20001459D0 NO20001459A NO20001459A NO20001459D0 NO 20001459 D0 NO20001459 D0 NO 20001459D0 NO 20001459 A NO20001459 A NO 20001459A NO 20001459 A NO20001459 A NO 20001459A NO 20001459 D0 NO20001459 D0 NO 20001459D0
- Authority
- NO
- Norway
- Prior art keywords
- colds
- conjunctivitis
- flu
- rhinitis
- symptoms
- Prior art date
Links
- 206010010741 Conjunctivitis Diseases 0.000 title 1
- 206010022004 Influenza like illness Diseases 0.000 title 1
- 239000000464 adrenergic agent Substances 0.000 title 1
- 229940125715 antihistaminic agent Drugs 0.000 title 1
- 239000000739 antihistaminic agent Substances 0.000 title 1
- 206010039083 rhinitis Diseases 0.000 title 1
- 239000000932 sedative agent Substances 0.000 title 1
- 230000001624 sedative effect Effects 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97116494A EP0903151A1 (en) | 1997-09-22 | 1997-09-22 | Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms |
| PCT/EP1998/005795 WO1999015203A1 (en) | 1997-09-22 | 1998-09-11 | Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20001459L NO20001459L (no) | 2000-03-21 |
| NO20001459D0 true NO20001459D0 (no) | 2000-03-21 |
Family
ID=8227389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20001459A NO20001459D0 (no) | 1997-09-22 | 2000-03-21 | Anvendelse av kombinasjoner som innbefatter ikke-sedative antihistaminer og <alfa>-adrenerge legemidler for topisk behandling av rhinitt/konjunktivitt og forkjølelse, forskjølelseslignende og/eller influensasymptomer |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20020037297A1 (xx) |
| EP (1) | EP0903151A1 (xx) |
| JP (1) | JP2001517639A (xx) |
| AU (1) | AU9540098A (xx) |
| BR (1) | BR9812361A (xx) |
| CA (1) | CA2304162A1 (xx) |
| DE (1) | DE19882573T1 (xx) |
| ES (1) | ES2171356B2 (xx) |
| NO (1) | NO20001459D0 (xx) |
| PL (1) | PL339541A1 (xx) |
| WO (1) | WO1999015203A1 (xx) |
| ZA (1) | ZA988638B (xx) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19954516A1 (de) * | 1999-11-12 | 2001-05-17 | Boehringer Ingelheim Int | Epinastin-haltige Lösungen |
| EP1276502A1 (en) * | 2000-04-14 | 2003-01-22 | J-Med Pharmaceuticals, Inc. | Single-dose antihistamine/decongestant formulations for treating rhinitis |
| SK2805U (sk) * | 2000-10-05 | 2001-03-12 | Unimed Pharma Spol Sro | Očná instilácia s dekongescentným účinkom |
| PE20020324A1 (es) * | 2000-10-06 | 2002-06-18 | Boehringer Ingelheim Int | Nuevas composiciones farmaceuticas que contienen epinastina y pseudoefedrina |
| US20020094345A1 (en) | 2000-10-06 | 2002-07-18 | Sara Abelaira | Pharmaceutical compositions containing epinastine and pseudoephedrine |
| FR2833493B1 (fr) * | 2001-12-18 | 2005-09-23 | Ioltechnologie Production | Forme galenique solide et soluble pour l'administration occulaire de principes actifs et procede de fabrication d'un insert ophtalmique solide et soluble |
| EP1327463A1 (de) * | 2002-01-04 | 2003-07-16 | Oramon Arzneimittel GmbH | Gel enthaltend Cetirizin und Loratadin zur topischen Anwendung |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| TW200402307A (en) * | 2002-06-20 | 2004-02-16 | Novartis Consumer Health Sa | Nasal composition |
| CN103143022A (zh) | 2002-07-30 | 2013-06-12 | 奥默罗斯公司 | 眼科冲洗液及方法 |
| CA2495830C (en) | 2002-08-30 | 2012-08-21 | Altana Pharma Ag | The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| US7714011B2 (en) * | 2002-09-13 | 2010-05-11 | Zicam, Llc | Compositions to reduce congestion and methods for application thereof to the nasal membrane |
| US20040198828A1 (en) * | 2003-01-17 | 2004-10-07 | Abelson Mark B. | Combinational use of long-acting and short-acting anti-histamines for ocular allergies |
| JP2007039473A (ja) * | 2003-02-19 | 2007-02-15 | Rohto Pharmaceut Co Ltd | 医薬組成物 |
| JP2010241834A (ja) * | 2003-02-19 | 2010-10-28 | Rohto Pharmaceut Co Ltd | 医薬組成物 |
| JP2005330245A (ja) * | 2004-05-21 | 2005-12-02 | Kowa Co | 鼻炎用薬 |
| DE102004049008A1 (de) | 2004-10-05 | 2006-04-06 | Merck Patent Gmbh | Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur |
| LT2486942T (lt) * | 2004-11-24 | 2019-01-25 | Meda Pharmaceuticals Inc. | Kompozicijos, apimančios azelastiną ir jų panaudojimo būdai |
| US20070020330A1 (en) | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
| US8758816B2 (en) | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
| US7247623B2 (en) * | 2005-08-19 | 2007-07-24 | Inspire Pharmaceuticals, Inc. | Method of treating dry eye disease with non-drying antihistamines |
| CA2650592A1 (en) * | 2006-04-26 | 2007-11-08 | Aciex, Inc. | Compositions for the treatment and prevention of eyelid swelling |
| US20090136598A1 (en) * | 2006-04-26 | 2009-05-28 | Aciex, Inc. | Compositions for the Treatment and Prevention of Eyelid Swelling |
| US7378082B1 (en) | 2007-11-05 | 2008-05-27 | Inspire Pharmaceuticals, Inc. | Method for treating allergic rhinitis without adverse effects |
| JP2008285474A (ja) * | 2007-04-17 | 2008-11-27 | Daiichi Sankyo Healthcare Co Ltd | 抗アデノウイルス剤を含有する医薬組成物 |
| US8952011B2 (en) | 2008-08-01 | 2015-02-10 | Eye Therapies Llc | Compositions and methods for the treatment of nasal conditions |
| WO2010014552A1 (en) * | 2008-08-01 | 2010-02-04 | Alpha Synergy Development, Inc. | Vasoconstriction compositions and methods of use |
| US20150119401A1 (en) * | 2008-08-01 | 2015-04-30 | Eye Therapies, Llc | Compositions and Methods for the Treatment of Nasal Conditions |
| US20110257188A1 (en) * | 2008-08-01 | 2011-10-20 | Gerald Horn | Compositions and methods for the treatment of nasal conditions |
| US12246013B2 (en) | 2008-08-01 | 2025-03-11 | Eye Therapies Llc | Vasoconstriction compositions and methods of use |
| US20120156244A1 (en) * | 2008-08-01 | 2012-06-21 | Alpha Synergy Development Inc. | Nasal Compositions and Uses Thereof |
| US8569273B2 (en) | 2009-03-17 | 2013-10-29 | Aciex Therapeutics, Inc. | Ophthalmic formulations of cetirizine and methods of use |
| PT3943069T (pt) * | 2009-03-17 | 2025-02-21 | Nicox Ophthalmics Inc | Formulações oftálmicas de cetirizina e métodos de utilização |
| US20120225918A1 (en) * | 2011-03-03 | 2012-09-06 | Voom, Llc | Compositions and Methods for Non-Surgical Treatment of Ptosis |
| JP5752578B2 (ja) * | 2011-12-09 | 2015-07-22 | ジェイ−メド ファーマシューティカルズ，インコーポレーティッド | 鼻炎治療のための単一投与抗ヒスタミン薬／鬱血除去薬製剤 |
| AU2013201465B2 (en) | 2012-10-24 | 2016-03-03 | Rayner Intraocular Lenses Limited | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
| US11135155B2 (en) | 2014-07-08 | 2021-10-05 | Hikma Pharmaceuticals Usa Inc. | Liquid naloxone spray |
| EP3212186A1 (en) * | 2014-10-31 | 2017-09-06 | Avon Products, Inc. | Topical compositions and methods of use thereof |
| TWI809304B (zh) | 2014-12-01 | 2023-07-21 | 奥默羅斯公司 | 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液 |
| DE102016125378A1 (de) * | 2016-12-22 | 2018-06-28 | Werner Schmidt | Zusammensetzung zur Behandlung von Erkältungskrankheiten |
| RU2744097C2 (ru) * | 2018-02-28 | 2021-03-02 | Акционерное Общество "Вертекс" | Комбинированное противоаллергическое лекарственное средство для назального применения |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3822349A (en) * | 1969-06-02 | 1974-07-02 | C Kosti | Vasoconstrictor-antihistamine composition for the treatment of hypertrophied oral tissue |
| JPH07188002A (ja) * | 1993-12-27 | 1995-07-25 | Taisho Pharmaceut Co Ltd | 鼻炎治療用組成物 |
-
1997
- 1997-09-22 EP EP97116494A patent/EP0903151A1/en not_active Withdrawn
-
1998
- 1998-09-11 PL PL98339541A patent/PL339541A1/xx unknown
- 1998-09-11 WO PCT/EP1998/005795 patent/WO1999015203A1/en active IP Right Grant
- 1998-09-11 CA CA002304162A patent/CA2304162A1/en not_active Abandoned
- 1998-09-11 AU AU95400/98A patent/AU9540098A/en not_active Abandoned
- 1998-09-11 ES ES200050020A patent/ES2171356B2/es not_active Expired - Fee Related
- 1998-09-11 DE DE19882573T patent/DE19882573T1/de not_active Withdrawn
- 1998-09-11 JP JP2000512571A patent/JP2001517639A/ja active Pending
- 1998-09-11 BR BR9812361-0A patent/BR9812361A/pt not_active Application Discontinuation
- 1998-09-21 ZA ZA988638A patent/ZA988638B/xx unknown
-
2000
- 2000-03-21 NO NO20001459A patent/NO20001459D0/no unknown
- 2000-12-14 US US09/737,252 patent/US20020037297A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999015203A1 (en) | 1999-04-01 |
| US20020037297A1 (en) | 2002-03-28 |
| NO20001459L (no) | 2000-03-21 |
| ES2171356B2 (es) | 2004-05-01 |
| CA2304162A1 (en) | 1999-04-01 |
| PL339541A1 (en) | 2000-12-18 |
| EP0903151A1 (en) | 1999-03-24 |
| ZA988638B (en) | 1999-03-23 |
| JP2001517639A (ja) | 2001-10-09 |
| AU9540098A (en) | 1999-04-12 |
| BR9812361A (pt) | 2000-09-19 |
| ES2171356A1 (es) | 2002-09-01 |
| DE19882573T1 (de) | 2000-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20001459D0 (no) | Anvendelse av kombinasjoner som innbefatter ikke-sedative antihistaminer og <alfa>-adrenerge legemidler for topisk behandling av rhinitt/konjunktivitt og forkjølelse, forskjølelseslignende og/eller influensasymptomer | |
| NO20033753L (no) | System og fremgangsmåte for håndtering av pasientomsorg | |
| NO20035323D0 (no) | Strikket substrat for anvendelse i medisinsk bandasjeprodukt, bandasjeprodukt og fremgangsmåte for tilveiebringelse av det samme | |
| NO20023818D0 (no) | Ny kombinasjon av ikke-beroligende antihistaminer med forbindelser som påvirker leukotrienvirkning for behandling avrhinitt/konjunktivitt | |
| NO20034430D0 (no) | Tiohydantoiner og anvendelse derav for behandling av diatbetes | |
| NO20050427L (no) | Carvedilolfosfatsalter og/eller solvater derav, tilsvarende preparater og/eller behandlingsfremgangsmater | |
| ATE345133T1 (de) | Laktose-freie, nicht-hygroskopische und wasserfreie pharmazeutische zusammensetzungen von descarboethoxyloratadin | |
| DK1095025T3 (da) | Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler | |
| NO20035120D0 (no) | 4-(fenyl-(piperidin-4-yl)-amino)-benzamidderivater og deres anvendelse vedbehandling av angst, smerte eller gastrointestinale forstyrrelser | |
| DE69728323D1 (de) | Variante des humanen C3a Rezeptors; diagnostische und therapeutische Verwendungen | |
| NO994673D0 (no) | Nye terapeutiske kombinasjoner av mirtazapin og antipsykotiske midler for behandling eller profylakse av psykotiske lidelser | |
| NO20031806D0 (no) | Anvendelse av pericytt apoptosehemmere for behandling og/eller forhindringav diabetisk retinopati | |
| NO993670D0 (no) | Quinoksalin i trippelkombinasjon med proteaseinhibitorer og reverse transkriptaseinhibitorer som medikament for behandling av AIDS | |
| ATE451934T1 (de) | Pharmazeutische zusammensetzung zur behandlung von rhinitiden | |
| NO20035116D0 (no) | 4-(fenylpiperidin-4-yliden-metyl)-benzamidderivater og deres anvendelse forbehandling av smerte, angst eller gastrointestinale forstyrrelser | |
| DK1265577T3 (da) | Medicinsk eller dentalmedicinsk behandlingsstol | |
| EE04263B1 (et) | Farmatseutiline kompositsioon piperidinoalkanoolantihistamiini ja selle derivaatide biosaadavuse suurendamiseks ning allergiliste reaktsioonide raviks patsiendil | |
| NO20033228L (no) | Anvendelse av IL-18 inhibitorer til behandling og/eller forhindring av hjertesykdom | |
| NO20035115D0 (no) | 4-(fenylpiperidin-4-yliden-metyl)-benzamidderivater og deres anvendelse forbehandling av smerte, angst eller gastrointestinale forstyrrelser | |
| NO994258D0 (no) | Anvendelse av levobupivakain eller ropivakain for behandling av migrene | |
| NO20035117D0 (no) | 4-(fenylpiperidin-4-yliden-metyl)-benzamidderivater og deres anvendelse forbehandling av smerte, angst eller gastrointestinale forstyrrelser | |
| NO20000229L (no) | Behandling av diabetes med tiazolidindion og sulfonylurea | |
| NO996264L (no) | Behandling av diabetes med tiazolidindion og sulfonylurea | |
| FI20040531A7 (fi) | Insuliiniresistenttien tilojen hoitaminen ja diagnosointi | |
| NO20035118D0 (no) | 4-(fenylpiperidin-4-yliden-metyl)-benzamidderivater og deres anvendelse forbehandling av smerte, angst eller gastrointestinale forstyrrelser |